We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$349B
AUM Growth
-$1.04B
Cap. Flow
+$12.6B
Cap. Flow %
3.6%
Top 10 Hldgs %
18.46%
Holding
3,713
New
104
Increased
2,394
Reduced
623
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 22.03%
2 Healthcare 12.31%
3 Financials 11.79%
4 Consumer Discretionary 9.84%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAIN
3451
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$33.5K ﹤0.01%
38,822
-6,860
-15% -$7.51K
GALT icon
3452
Galectin Therapeutics
GALT
$196M
$33.4K ﹤0.01%
17,413
HYFM icon
3453
Hydrofarm Holdings
HYFM
$2.57M
$33.1K ﹤0.01%
2,715
NEOV icon
3454
NeoVolta
NEOV
$116M
$32.3K ﹤0.01%
12,964
WRAP icon
3455
Wrap Technologies
WRAP
$103M
$32.3K ﹤0.01%
21,515
CTMX icon
3456
CytomX Therapeutics
CTMX
$675M
$32K ﹤0.01%
24,817
CATX icon
3457
Perspective Therapeutics
CATX
$332M
$31.8K ﹤0.01%
11,601
STTK icon
3458
Shattuck Labs
STTK
$675M
$31.7K ﹤0.01%
20,881
MLSS icon
3459
Milestone Scientific
MLSS
$35.3M
$31.6K ﹤0.01%
34,400
SUP
3460
DELISTED
Superior Industries International
SUP
$31.5K ﹤0.01%
10,350
DYAI icon
3461
Dyadic International
DYAI
$38.3M
$31.4K ﹤0.01%
16,336
BEAT icon
3462
Heartbeam
BEAT
$27.8M
$31.3K ﹤0.01%
14,543
USIO icon
3463
Usio Inc
USIO
$58.8M
$31.1K ﹤0.01%
17,787
GTHX
3464
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$31K ﹤0.01%
21,516
-218,093
-91% -$422K
VANI icon
3465
Vivani Medical
VANI
$110M
$30.6K ﹤0.01%
30,017
FARM
3466
DELISTED
Farmer Brothers
FARM
$30.4K ﹤0.01%
11,781
ORKA
3467
Oruka Therapeutics
ORKA
$5.82B
$30.1K ﹤0.01%
1,249
CTSO icon
3468
Cytosorbents Corp
CTSO
$22.7M
$30.1K ﹤0.01%
15,994
-500
-3% -$1.44K
HYPR icon
3469
Hyperfine
HYPR
$92.9M
$30K ﹤0.01%
14,647
SMSI icon
3470
Smith Micro Software
SMSI
$14.5M
$29.9K ﹤0.01%
618
WKSP icon
3471
Worksport
WKSP
$9.71M
$29.2K ﹤0.01%
1,392
AQST icon
3472
Aquestive Therapeutics
AQST
$463M
$29.2K ﹤0.01%
19,078
IDN icon
3473
Intellicheck
IDN
$73.1M
$28.8K ﹤0.01%
12,962
ASMB icon
3474
Assembly Biosciences
ASMB
$498M
$28.7K ﹤0.01%
2,704
SCOR icon
3475
Comscore
SCOR
$106M
$28.3K ﹤0.01%
2,303

Similar funds

Charles Schwab's Q3 2023 Portfolio in Review

As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.

  • Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
  • Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
  • Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
  • Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
  • Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
  • Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
  • Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.